Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)
South Korea
· Delayed Price · Currency is KRW
3,450.00
+5.00 (0.15%)
Nov 15, 2024, 3:30 PM KST
Hyundai Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is December - November.
Millions KRW. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | 2008 - 2004 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 | 2008 - 2004 |
Net Income | 1,415 | 1,415 | -4,850 | 520.1 | 2,968 | 1,671 | Upgrade
|
Depreciation & Amortization | 2,111 | 2,111 | 2,357 | 2,470 | 2,289 | 2,605 | Upgrade
|
Loss (Gain) From Sale of Assets | -340.5 | -340.5 | 222.21 | 92.68 | -5,137 | 262.18 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | -2.83 | -14.9 | - | -487.31 | Upgrade
|
Loss (Gain) on Equity Investments | - | - | - | - | -146.24 | 9.29 | Upgrade
|
Provision & Write-off of Bad Debts | -2.66 | -2.66 | 129.53 | 30.9 | 65.71 | 192.98 | Upgrade
|
Other Operating Activities | 2,306 | 2,306 | 767.03 | 3,242 | 4,847 | 3,876 | Upgrade
|
Change in Accounts Receivable | 529.73 | 529.73 | 10,802 | 3,372 | 1,951 | -8,893 | Upgrade
|
Change in Inventory | 1,977 | 1,977 | -8,274 | -3,540 | 17.31 | -3,671 | Upgrade
|
Change in Accounts Payable | 1,362 | 1,362 | 505.08 | 1,894 | -1,971 | 1,521 | Upgrade
|
Change in Unearned Revenue | - | - | -6.75 | -69.3 | - | - | Upgrade
|
Change in Income Taxes | - | - | - | - | 623.28 | 456.44 | Upgrade
|
Change in Other Net Operating Assets | -1,406 | -1,406 | -4,348 | -1,729 | -2,737 | -4,091 | Upgrade
|
Operating Cash Flow | 7,951 | 7,951 | -2,697 | 6,268 | 2,678 | -6,889 | Upgrade
|
Operating Cash Flow Growth | - | - | - | 134.03% | - | - | Upgrade
|
Capital Expenditures | -2,241 | -2,241 | -1,457 | -3,682 | -3,946 | -2,327 | Upgrade
|
Sale of Property, Plant & Equipment | 422.59 | 422.59 | 6,762 | 1,381 | 48.27 | 698.38 | Upgrade
|
Sale (Purchase) of Intangibles | 586.43 | 586.43 | -121.82 | -334.53 | -46.79 | -44.84 | Upgrade
|
Investment in Securities | 519.3 | 519.3 | -376.03 | -291.93 | 183.7 | -1,694 | Upgrade
|
Other Investing Activities | -0 | -0 | 0 | -0 | -394.25 | -303.27 | Upgrade
|
Investing Cash Flow | -713.02 | -713.02 | 4,807 | -2,928 | 5,915 | -3,262 | Upgrade
|
Short-Term Debt Issued | 6,000 | 6,000 | 9,286 | 1,685 | 12,000 | 12,000 | Upgrade
|
Total Debt Issued | 6,000 | 6,000 | 9,286 | 1,685 | 12,000 | 12,000 | Upgrade
|
Short-Term Debt Repaid | -14,536 | -14,536 | -7,819 | -2,000 | -13,522 | -6,790 | Upgrade
|
Total Debt Repaid | -14,536 | -14,536 | -7,819 | -2,000 | -13,522 | -6,790 | Upgrade
|
Net Debt Issued (Repaid) | -8,536 | -8,536 | 1,467 | -314.65 | -1,522 | 5,210 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 1,471 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -2,058 | -1,477 | Upgrade
|
Common Dividends Paid | - | - | - | - | -1,224 | -1,599 | Upgrade
|
Dividends Paid | -881.7 | -881.7 | -938.61 | -1,056 | -1,224 | -1,599 | Upgrade
|
Other Financing Activities | -0 | -0 | -0 | - | - | 1,202 | Upgrade
|
Financing Cash Flow | -9,418 | -9,418 | 528.39 | -1,370 | -4,804 | 4,807 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
Net Cash Flow | -2,180 | -2,180 | 2,638 | 1,970 | 3,789 | -5,344 | Upgrade
|
Free Cash Flow | 5,710 | 5,710 | -4,154 | 2,586 | -1,267 | -9,216 | Upgrade
|
Free Cash Flow Margin | 5.28% | 5.28% | -4.06% | 2.26% | -1.13% | -7.50% | Upgrade
|
Free Cash Flow Per Share | 243.49 | 243.49 | -177.31 | 109.37 | -53.09 | -374.72 | Upgrade
|
Cash Interest Paid | 968.45 | 968.45 | 1,279 | 1,359 | - | - | Upgrade
|
Cash Income Tax Paid | 408.34 | 408.34 | 1,228 | 1,101 | - | - | Upgrade
|
Levered Free Cash Flow | 6,292 | 6,292 | -1,444 | -3,010 | 3,464 | -4,627 | Upgrade
|
Unlevered Free Cash Flow | 6,900 | 6,900 | -651.34 | -2,163 | 4,260 | -3,869 | Upgrade
|
Change in Net Working Capital | -5,078 | -5,078 | -1,269 | 2,779 | -3,248 | 7,978 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.